Research ExplorerPublicationsVascular endothelial growth factor (VEGF) in sera of oral an...

Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.

Standard

Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients. / Friedrich, Reinhard; Klapdor, Rainer; Hagel, Christian; Bartel-Friedrich, Sylva.

In: ANTICANCER RES, Vol. 30, No. 5, 5, 2010, p. 1765-1766.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Friedrich, R, Klapdor, R, Hagel, C & Bartel-Friedrich, S 2010, 'Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.', ANTICANCER RES, vol. 30, no. 5, 5, pp. 1765-1766. <http://www.ncbi.nlm.nih.gov/pubmed/20592375?dopt=Citation>

APA

Friedrich, R., Klapdor, R., Hagel, C., & Bartel-Friedrich, S. (2010). Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients. ANTICANCER RES, 30(5), 1765-1766. [5]. http://www.ncbi.nlm.nih.gov/pubmed/20592375?dopt=Citation

Vancouver

Friedrich R, Klapdor R, Hagel C, Bartel-Friedrich S. Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients. ANTICANCER RES. 2010;30(5):1765-1766. 5.

Bibtex

@article{b3ca53982088473b89bbff1b25db064a,
title = "Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.",
abstract = "This study was performed to investigate the serum levels of vascular endothelial growth factor (VEGF) in patients with oral and oropharyngeal cancer. The study population included 86 patients with untreated cancer of this region. VEGF serum levels varied considerably and showed no correlation to tumour size or locoregional spread. The wide variety of VEGF serum levels make this marker difficult to handle for initial diagnostics or monitoring of therapy.",
author = "Reinhard Friedrich and Rainer Klapdor and Christian Hagel and Sylva Bartel-Friedrich",
year = "2010",
language = "Deutsch",
volume = "30",
pages = "1765--1766",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

RIS

TY - JOUR

T1 - Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.

AU - Friedrich, Reinhard

AU - Klapdor, Rainer

AU - Hagel, Christian

AU - Bartel-Friedrich, Sylva

PY - 2010

Y1 - 2010

N2 - This study was performed to investigate the serum levels of vascular endothelial growth factor (VEGF) in patients with oral and oropharyngeal cancer. The study population included 86 patients with untreated cancer of this region. VEGF serum levels varied considerably and showed no correlation to tumour size or locoregional spread. The wide variety of VEGF serum levels make this marker difficult to handle for initial diagnostics or monitoring of therapy.

AB - This study was performed to investigate the serum levels of vascular endothelial growth factor (VEGF) in patients with oral and oropharyngeal cancer. The study population included 86 patients with untreated cancer of this region. VEGF serum levels varied considerably and showed no correlation to tumour size or locoregional spread. The wide variety of VEGF serum levels make this marker difficult to handle for initial diagnostics or monitoring of therapy.

M3 - SCORING: Zeitschriftenaufsatz

VL - 30

SP - 1765

EP - 1766

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 5

M1 - 5

ER -